News

By Priscila Mayumi Kashiwabara

Life sciences patent eligibility in Latin America: a guide

Patents are critical to the life sciences industry and often spark intense and heated debate. To be successful, one key strategy that should be pursued by life sciences companies is building and maintaining a patent portfolio capable of distinguishing itself from competitors, as well as representing a well-reasoned business strategy. Companies should secure their patent assets by maximising patent coverage of the core technology and its potential improvements. One reason is that patents can demonstrate the commercial potential of a company’s technology, they are also the driving force for major events in the lifecycle of a life sciences company.

Access the full guide, published by IAM and written by Priscila Kashiwabara, Marisa Momoli and Livia Figueiredo by clicking here.
Back

Last by Priscila Mayumi Kashiwabara

17 de June de 2025

Brazil Ratifies the Budapest Treaty: A Strategic Step to Strengthen Biotechnological Innovation

On June 11th, 2025, the Brazilian Senate approved Legislative Decree No. 466/2022, ratifying Brazil’s accession to the Budapest Treaty on the International Brazil Ratifies the Budapest Treaty: A Strategic Step to Strengthen Biotechnological Innovation

Ler notícia

29 de May de 2025

Kasznar Leonardos was ranked on IAM Patent 1000

We are proud to announce that we have been ranked in the IAM Patent 1000 2025, a specialized ranking in the field Kasznar Leonardos was ranked on IAM Patent 1000

Ler notícia

15 de April de 2025

Federal Senate approves Bill Extending Plant Variety Protection Term, but Chamber of Deputies Approval is Still Required

The Federal Senate has approved a bill (PLS nº 404/2018) that extends the protection period for new plant varieties (cultivars). According to Federal Senate approves Bill Extending Plant Variety Protection Term, but Chamber of Deputies Approval is Still Required

Ler notícia